ÂÜÀòÂÒÂ×

Henry Chen

Co-Founder & Director at Tulavi Therapeutics

Henry is the Managing Partner and co-Founder of Delos Capital. Mr. Chen also sits on the boards of Imperative Care, BaroNova, Atia Vision, Tanvex BioPharma, Allecra Therapeutics and Syndax Pharmaceuticals. Prior to establishing Delos in 2014, Mr. Chen was a Partner and Co-Head of Asia at Permira, a European private equity firm with global reach and a total committed capital of approximately €20bn. While at Permira, Mr. Chen worked on a number of transactions including Asia Broadcast Satellite and Galaxy Entertainment Group. Prior to joining Permira in 2008, Mr. Chen spent nine years in Investment Banking at Goldman Sachs, where he was a Managing Director and co-headed the General Industrials Group, Asia (excluding Japan) which covered consumer retail, healthcare, industrials and transportation sectors. Prior to that, Mr. Chen was a corporate finance lawyer with Davis Polk in New York and Hong Kong. Mr. Chen holds Bachelor and Masters degrees from Harvard University and has a Juris Doctorate degree from Harvard Law School.